Offer - Urjas Oil for just ₹ 1 X
Sebifin Plus is a commercial drug that is prescribed in the form of Cream. Sebifin Plus also has some secondary and off-label uses. These are listed below.
The optimal dosage of Sebifin Plus is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Sebifin Plus also has some side effects, the most common being Headache, Chills, Cough. Apart from the aforementioned side effects, Sebifin Plus can also lead to other problems, which have been listed below. These side effects of Sebifin Plus are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Sebifin Plus is Safe for pregnant women and Severe for women who are breastfeeding. It is important to know if Sebifin Plus has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Sebifin Plus related warnings section.
Other conditions have been mentioned below in the Sebifin Plus contraindications section.
Additionally, Sebifin Plus may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Sebifin Plus is not safe while driving, and is is not addictive in nature.
Sebifin Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Sebifin Plus safe for pregnant women?
Sebifin Plus is safe for pregnant women.
Is the use of Sebifin Plus safe during breastfeeding?
Sebifin Plus may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Sebifin Plus on the Kidneys?
Sebifin Plus may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Sebifin Plus on the Liver?
You may experience side effects on your liver after taking Sebifin Plus. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Sebifin Plus on the Heart?
Using Sebifin Plus does not have any harmful effects on the heart.
Sebifin Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Sebifin Plus unless your doctor advises you to do so -
Is this Sebifin Plus habit forming or addictive?
No, you will not get addicted to Sebifin Plus.
Interaction between Food and Sebifin Plus
It is safe to take Sebifin Plus with food.
Interaction between Alcohol and Sebifin Plus
Information about the interaction of Sebifin Plus and alcohol is not currently available because this topic has not been researched yet.
No, Sebifin Plus should not be applied to children under the age of 2 years as the safety and efficacy have not been established yet in this age group.
Yes, Sebifin Plus can be used for the treatment of brown patches on the skin or melasma, however, it is not used alone. It is always used in combination with hydroquinone, isotretinoin and sometimes glycolic acid. Melasma is a common skin condition. It is usually manifested as brown to gray-brown patches on the forehead, bridge of the nose, cheeks, upper lip, and chin. It can also invade forearms and neck. Alongside topical treatment, protection from Sun is also suggested as a treatment.
Sebifin Plus works by releasing some anti-inflammatory proteins and inhibiting the synthesis of some inflammation mediators. This provides relief to the patient temporarily.
No, Sebifin Plus should not be used on a diaper rash as the diaper might contain an occlusive dressing which might be air and water tight causing an irritant effect on the skin of a child. Diaper rash appears as an inflamed skin portion (also known as dermatitis) on the bottoms of a baby. It develops because of wet and infrequently changed diapers, chafing and also because of the skin sensitivity. It can be cured by using good quality diapers, air drying, frequent changing of the diapers and using an ointment containing ingredients like zinc oxide, calendula, etc.
Sebifin Plus is a topical corticosteroid which is used for treating conditions like psoriasis and eczema. It is not to be used on face and that too for treating acne. Acne can be treated by using anti-acne preparations containing active ingredients like alpha-hydroxy acids, benzoyl peroxide, salicylic acid, clay, sulfur, etc. Acne is rather one of the side effects caused by Sebifin Plus.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elocon® (mometasone furoate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nasonex® (mometasone furoate monohydrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Asmanex® Twisthaler® (mometasone furoate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177